Research ArticleOriginal Research

Maternal Chemical and Drug Intolerances: Potential Risk Factors for Autism and Attention Deficit Hyperactivity Disorder (ADHD)

Lynne P. Heilbrun, Raymond F. Palmer, Carlos R. Jaen, Melissa D. Svoboda, Jimmy Perkins and Claudia S. Miller
The Journal of the American Board of Family Medicine July 2015, 28 (4) 461-470; DOI: https://doi.org/10.3122/jabfm.2015.04.140192

References

  1. 1.↵
    1. Boyle CA,
    2. Boulet SL,
    3. Schieve LA,
    4. et al
    . Trends in the prevalence of developmental disabilities in U.S. children, 1997–2008. Pediatrics 2011;127:1034–42.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Blumberg SJ,
    2. Bramlett MD,
    3. Kogan MD,
    4. Schieve LA,
    5. Jones JR,
    6. Lu MC
    . Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. children: 2007 to 2011–2012. Natl Health Stat Report 2013;(65):1–11, 1 p following 11.
  3. 3.↵
    1. Hertz-Picciotto I,
    2. Delwiche L
    . The rise in autism and the role of age at diagnosis. Epidemiology 2009;20:84–90.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    Centers for Disease Control and Prevention (CDC). Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children—United States, 2003 and 2007. MMWR Morb Mortal Wkly Rep 2010;59:1439–43.
    OpenUrlPubMed
  5. 5.↵
    1. Toomey SL,
    2. Finkelstein J,
    3. Kuhlthau K
    . Does connection to primary care matter for children with attention-deficit/hyperactivity disorder? Pediatrics 2008;122:368–74.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Brachlow AE,
    2. Ness KK,
    3. McPheeters ML,
    4. Gurney JG
    . Comparison of indicators for a primary care medical home between children with autism or asthma and other special health care needs: National Survey of Children's Health. Arch Pediatr Adolesc Med 2007;161(4):399–405.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Kogan MD,
    2. Strickland BB,
    3. Blumberg SJ,
    4. Singh GK,
    5. Perrin JM,
    6. van Dyck PC
    . A national profile of the health care experiences and family impact of autism spectrum disorder among children in the United States, 2005–2006. Pediatrics 2008;122:e1149–58.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Leslie L
    . The role of primary care physicians in attention deficit hyperactivity disorder (ADHD). Pediatr Ann 2002;31:475–84.
    OpenUrlPubMedWeb of Science
  9. 9.↵
    1. Golnick AE,
    2. Ireland M
    . Complementary alternative medicine for children with autism: a physician survey. J Autism Dev Disord 2009;39:996–1005.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Hallmayer J,
    2. Cleveland S,
    3. Torres A,
    4. et al
    . Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011;68:1095–102.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Wigle DT,
    2. Arbuckle TE,
    3. Walker M,
    4. Wade MG,
    5. Liu S,
    6. Krewski D
    . Environmental hazards: evidence for effects on child health. J Toxicol Environ Health B Crit Rev 2007;10:3–39.
    OpenUrlPubMedWeb of Science
  12. 12.↵
    1. Pessah I,
    2. Seegal RF,
    3. Lein PJ,
    4. et al
    . Immunologic and neurodevelopmental susceptibilities of autism. Neurotoxicology 2008;29:532–45.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Hertz-Picciotto I,
    2. Park HY,
    3. Dostal M,
    4. Kocan A,
    5. Trnovec T,
    6. Sram R
    . Prenatal exposures to persistent and non-persistent organic compounds and effects on immune system development. Basic Clin Pharmacol Toxicol 2008;102:146–54.
    OpenUrlPubMedWeb of Science
  14. 14.↵
    1. Rauh VA,
    2. Garfinkel R,
    3. Perera FP,
    4. et al
    . Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children. Pediatrics 2006;118:1845–59.
    OpenUrlCrossRef
  15. 15.↵
    1. Bouchard MF,
    2. Bellinger DC,
    3. Wright RO,
    4. Weisskopf MG
    . Attention-deficit/hyperactivity disorder and urinary metabolites of organophosphate pesticides. Pediatrics 2010;125(6):e1270–7.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Rosas LG,
    2. Eskenazi B
    . Pesticides and child neurodevelopment. Curr Opin Pediatr 2008;20:191–7.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Siddique S,
    2. Banerjee M,
    3. Ray MR,
    4. Lahiri T
    . Attention-deficit hyperactivity disorder in children chronically exposed to high level of vehicular pollution. Eur J Pediatr 2011;170:923–9.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Volk HE,
    2. Lurmann F,
    3. Penfold B,
    4. Hertz-Picciotto I,
    5. McConnell R
    . Traffic-related air pollution, particulate matter, and autism. JAMA Psychiatry 2013;70:71–7.
    OpenUrlPubMed
  19. 19.↵
    1. Palmer RF,
    2. Blanchard S,
    3. Wood R
    . Proximity to point sources of environmental mercury release as a predictor of autism prevalence. Health Place 2009;15:18–24.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Weschler CJ
    . Changes in indoor pollutants since the 1950s. Atmos Environ 2009;43:153–69.
    OpenUrlCrossRefWeb of Science
  21. 21.↵
    1. Sundell J
    . Indoor environments and health. Presented at the First International Conference on Sustainable Healthy Buildings, Seoul, Korea, 2009.
  22. 22.↵
    1. Kalkbrenner AE,
    2. Daniels JL,
    3. Chen JC,
    4. Poole C,
    5. Emch M,
    6. Morrissey J
    . Perinatal exposure to hazardous air pollutants and autism spectrum disorders at age 8. Epidemiology 2010;21:631–41.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Croen L,
    2. Grether JK,
    3. Yoshida CK,
    4. Odouli R,
    5. Hendrick V
    . Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry 2011;68:1104–12.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Figueroa R
    . Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring. J Dev Behav Pediatr 2010;31:641–8.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Strömland V,
    2. Nordin M,
    3. Miller B,
    4. Akerström B,
    5. Gillberg C
    . Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol 1994;36:351–6.
    OpenUrlPubMedWeb of Science
  26. 26.↵
    1. Arndt TL,
    2. Stodgell CJ,
    3. Rodier PM
    . The teratology of autism. Int J Dev Neurosci 2005;23:189–99.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Bandim JM,
    2. Ventura LO,
    3. Miller MT,
    4. Almeida HC,
    5. Costa AE
    . Autism and Möbius sequence: an exploratory study of children in northeastern Brazil. Arq Neuropsiquiatr. 2003.
  28. 28.↵
    1. Moore SJ,
    2. Turnpenny P,
    3. Quinn A,
    4. et al
    . A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 2000;37:489–97.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Rodier PM
    . Converging evidence for brain stem injury in autism. Dev Psychopathol 2002;14:537–57.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Kruetzer R,
    2. Neutra R,
    3. Lashuay N
    . Prevalence of people reporting sensitivities to chemicals in a population-based survey. Am J Epidemiol 1999;150:1–12.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Bell IR,
    2. Schwartz GE,
    3. Peterson JM,
    4. Amend D
    . Self-reported illness from chemical odors in young adults without clinical syndromes or occupational exposures. Arch Environ Health 1993;48:6–13.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Bell IR,
    2. Hardin EE,
    3. Baldwin CM,
    4. Schwartz GE
    . Increased limbic system symptomatology and sensitizability of young adults with chemical and noise sensitivities. Environ Res 1995;70:84–97.
    OpenUrlPubMedWeb of Science
  33. 33.↵
    1. Bell IR,
    2. Peterson JM,
    3. Schwartz GE
    . Medical histories and psychological profiles of middle-aged women with and without self-reported illness from environmental chemicals. J Clin Psychiatry 1995;56:151–60.
    OpenUrlPubMedWeb of Science
  34. 34.↵
    1. Caress SM,
    2. Steinemann AC
    . A national population study of the prevalence of multiple chemical sensitivity. Arch Intern Med 2004;59:300–5.
    OpenUrl
  35. 35.↵
    1. Katerndahl DA,
    2. Bell IR,
    3. Palmer RF,
    4. Miller GS
    . Chemical intolerance in primary care settings: prevalence, comorbidity, and outcomes. Ann Fam Med 2012;10:357–65.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Miller CS
    . Toxicant-induced loss of tolerance. Addiction 2001;96:115–37.
    OpenUrlCrossRefPubMedWeb of Science
  37. 37.↵
    1. Miller CS,
    2. Prihoda TJ
    . A controlled comparison of symptoms and chemical intolerances reported by Gulf War veterans, implant recipients and persons with multiple chemical sensitivity. Toxicol Ind Health 1999;15:386–97.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Miller CS,
    2. Prihoda TJ
    . The Environmental Exposure and Sensitivity Inventory (EESI): a standardized approach for measuring chemical intolerances for research and clinical applications. Toxicol Ind Health 1999;15:370–85.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Hojo S,
    2. Kumano H,
    3. Yoshino H,
    4. Kakuta K,
    5. Ishikawa S
    . Application of Quick Environment Exposure Sensitivity Inventory (QEESI) for Japanese population: study of reliability and validity of the questionnaire. Toxicol Ind Health 2003;19:41–9.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Schnakenberg E,
    2. Fabig KR,
    3. Stanulla M,
    4. et al
    . A cross-sectional study of self-reported chemical-related sensitivity is associated with gene variants of drug-metabolizing enzymes. Environ Health 2007;6:6.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Skovbjerg S,
    2. Berg ND,
    3. Elberling J,
    4. Christensen KB
    . Evaluation of the Quick Environmental Exposure and Sensitivity Inventory in a Danish population. J Environ Public Health 2012;2012:304314.
    OpenUrlPubMed
  42. 42.↵
    1. Lee H,
    2. Marvin AR,
    3. Watson T,
    4. et al
    . Accuracy of phenotyping of autistic children based on internet implemented parent report. Am J Med Genet B Neuropsychatr Genet 2010;153B:1119–26.
    OpenUrl
  43. 43.↵
    1. Daniels AM,
    2. Rosenberg RE,
    3. Anderson C,
    4. Law JK,
    5. Marvin AR,
    6. Law PA
    . Verification of parent-report of child autism spectrum disorder diagnosis to a web-based autism registry. J Autism Dev Disord 2012;42:257–65.
    OpenUrlCrossRefPubMed
  44. 44.↵
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition, text rev. Washington, DC: APA; 2000.
  45. 45.↵
    1. Westfall PH,
    2. Tobias RD,
    3. Rom D,
    4. Wolfinger RD,
    5. Hochberg Y
    . Multiple comparisons and multiple tests using the SAS system. Cary, NC: SAS Institute; 1999.
  46. 46.↵
    1. Lajiness-O'Neill R,
    2. Menard P
    . Brief report: an autistic spectrum subtype revealed through familial psychopathology coupled with cognition in ASD. J Autism Dev Disord 2008;38:982–7.
    OpenUrlPubMed
  47. 47.↵
    1. Schachar RJ,
    2. Wachsmuth R
    . Hyperactivity and parental psychopathology. J Child Psychol Psychiatry 1990;31:381–92.
    OpenUrlCrossRefPubMedWeb of Science
  48. 48.↵
    1. Davis C,
    2. Curtis C,
    3. Levitan RD,
    4. Carter JC,
    5. Kaplan AS,
    6. Kennedy JL
    . Evidence that “food addiction” is a valid phenotype of obesity. Appetite 2011;57:711–7.
    OpenUrlCrossRefPubMed
  49. 49.↵
    1. Gruss B,
    2. Mueller A,
    3. Horbach T,
    4. Martin A,
    5. de Zwaan M
    . Attention-deficit/hyperactivity disorder in a prebariatric surgery sample. Eur Eat Disord Rev 2012;20:e103–7.
    OpenUrlPubMed
  50. 50.↵
    1. Macfabe D
    . Autism: metabolism, mitochondria, and the microbiome. Glob Adv Health Med 2013;2:52–66.
    OpenUrlCrossRefPubMed
  51. 51.↵
    1. De Luca C,
    2. Gugliandolo A,
    3. Calabrò C,
    4. Currò M,
    5. Ientile R,
    6. Raskovic D,
    7. et al
    . Role of polymorphisms of inducible nitric oxide synthase and endothelial nitric oxide synthase in idiopathic environmental intolerances. Mediators Inflamm. 2015; Epub 2015 Mar 24.
  52. 52.↵
    1. Gaita L,
    2. Manzi B,
    3. Sacco R,
    4. et al
    . Decreased serum arylesterase activity in autism spectrum disorders. Psychiatry Res 2010;180:105–13.
    OpenUrlCrossRefPubMed
  53. 53.↵
    1. Furlong CE,
    2. Holland N,
    3. Richter RJ,
    4. Bradman A,
    5. Ho A,
    6. Eskenazi B
    . PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity. Pharmacogenet Genomics 2006;16:183–90.
    OpenUrlPubMedWeb of Science
  54. 54.↵
    1. Singh S,
    2. Kumar V,
    3. Thakur S,
    4. et al
    . DNA damage and cholinesterase activity in occupational workers exposed to pesticides. Environ Toxicol Pharmacol 2011;31:278–85.
    OpenUrlCrossRefPubMed
  55. 55.↵
    1. Singh S,
    2. Kumar V,
    3. Thakur S,
    4. et al
    . Paraoxonase-1 genetic polymorphisms and susceptibility to DNA damage in workers occupationally exposed to organophosphate pesticides. Toxicol Appl Pharmacol 2011;252:130–7.
    OpenUrlCrossRefPubMed
  56. 56.↵
    1. Kozhimannil KB,
    2. Fontaine P
    . Care from family physicians reported by pregnant women in the United States. Ann Fam Med 2013;11:350–4.
    OpenUrlAbstract/FREE Full Text
  57. 57.↵
    American College of Obstetricians and Gynecologists. Exposure to toxic environmental agents. Washington DC: ACOG; 2013.
  58. 58.↵
    1. Mickelson KD
    . Seeking social support: parents in electronic support groups. Culture of the Internet. Mahwah, NJ: Erlbaum;1997:157–78.
  59. 59.↵
    1. Losh SC
    . Generation, education, gender and ethnicity in American digital divides. In: Handbook of research on overcoming digital divides: constructing an equitable and competitive information society. Vol. 1. Hershey, PA: IGI Global;2009:196–222.
    OpenUrl
  60. 60.↵
    1. Mickelson KD,
    2. Wroble M,
    3. Helgeson VS
    . “Why my child?”: parental attributions for children's special needs1. J Applied Soc Psychol 1999;29:1263–91.
    OpenUrl
  61. 61.↵
    1. Wacholder S,
    2. Silverman DT,
    3. McLaughlin JK,
    4. Mandel JS
    . Selection of controls in case-control studies: III. Design options. Am J Epidemiol 1992;135:1042–50.
    OpenUrlAbstract/FREE Full Text
  62. 62.↵
    1. Miller CS,
    2. Mitzel HC
    . Chemical sensitivity attributed to pesticide exposure versus remodeling. Arch Environ Health. 1995;50:119–29.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords